Suppr超能文献

采用第二代酶联免疫吸附试验和线性免疫测定法对医护人员丙型肝炎患病率进行调查。

Prevalence of hepatitis C in health care workers investigated by 2nd generation enzyme-linked and line immunoassays.

作者信息

Frider B, Sookoian S, Castaño G, Rébora N, Gutfraind Z, Mirta K, Veyretou F, Wainstein C

机构信息

Internal Medicine Division, Argerich County Hospital, University of Buenos Aires, Argentina.

出版信息

Acta Gastroenterol Latinoam. 1994;24(2):71-5.

PMID:7817696
Abstract

The aim of this study was to evaluate the prevalence of antibodies to hepatitis C virus (anti-HCV) in health-care workers (HCW). Sera from 439 unselected HCW were assessed for anti-HCV by 2nd generation enzyme-linked immunoassay (ELISA) and anti-HBc by ELISA. Anti-HCV (+) sera were evaluated by line immunoassay (LIA) (LiaTeK, Organon). Anti-HCV proved positive by ELISA in 12 (2.73%) subjects, 6 of whom were reactive by LIA, one was indeterminate and 5 non reactive. The prevalence of anti-HCV confirmed by LIA was 1.59% (7 subjects). Positive anti-HCV results with an ELISA ratio greater than 3 were LIA reactive in 6/6 as compared with 5 LIA non reactive with an ELISA ratio less than 2, while in the indeterminate serum the ratio was 2.5. No differences in age, profession, seniority, history of hepatitis or transfusions were found between anti-HCV (+) and (-) subjects, but females predominate significantly. The areas of higher risk were hemodialysis, obstetrics, surgery and intensive care. Anti-HBc was (+) in 85.7% (6/7) of the anti-HCV (+) subjects. Follow-up of anti-HCV (+) subjects showed raised alaninoaminotransferase levels in 4 cases, while liver biopsies in 3 disclosed cirrhosis, chronic active hepatitis and chronic persistent hepatitis. The anti-HCV prevalence in HCW is low compared with other risk groups perhaps due to the peculiar epidemiological features of HCV. In low risk groups for HCV infection a positive ELISA result with a ratio lower than 3 should be confirmed by more specific tests.

摘要

本研究旨在评估医护人员(HCW)中丙型肝炎病毒抗体(抗-HCV)的流行情况。采用第二代酶联免疫吸附测定(ELISA)对439名未经挑选的医护人员的血清进行抗-HCV检测,并采用ELISA检测抗-HBc。抗-HCV(+)血清通过线性免疫测定(LIA)(LiaTeK,欧加农公司)进行评估。ELISA检测显示12名(2.73%)受试者抗-HCV呈阳性,其中6名通过LIA检测呈反应性,1名结果不确定,5名无反应性。经LIA确认的抗-HCV流行率为1.59%(7名受试者)。ELISA比值大于3的抗-HCV阳性结果中,6/6通过LIA检测呈反应性,而ELISA比值小于2的5名受试者LIA检测无反应性,结果不确定的血清其比值为2.5。抗-HCV(+)和(-)受试者在年龄、职业、资历、肝炎病史或输血史方面未发现差异,但女性占比显著更高。高风险领域为血液透析、产科、外科和重症监护。抗-HCV(+)受试者中85.7%(6/7)抗-HBc呈阳性。对抗-HCV(+)受试者的随访显示,4例丙氨酸氨基转移酶水平升高,而3例肝活检显示为肝硬化、慢性活动性肝炎和慢性持续性肝炎。与其他风险群体相比,医护人员中抗-HCV的流行率较低,这可能归因于HCV独特的流行病学特征。在HCV感染低风险群体中,ELISA比值低于3的阳性结果应用更特异的检测方法进行确认。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验